Embla Medical hf (OTCPK:OSSFF)
$ 5.1 0 (0%) Market Cap: 2.13 Bil Enterprise Value: 2.57 Bil PE Ratio: 31.48 PB Ratio: 2.87 GF Score: 79/100

Q2 2019 Ossur hf Earnings Call Transcript

Jul 25, 2019 / 07:00AM GMT
Release Date Price: $6.42
Operator

Ladies and gentlemen, welcome to Ãssur Q2 Results 2019. Today, I am pleased to present Mr. Jón Sigurdsson, President and CEO; and Mr. Sveinn Sölvason, CFO. (Operator Instructions) Mr. Sigurdsson and Mr. Sölvason, please begin.

Jón Sigurdsson;ssur hf.;CEO;President
Ã

&

Yes. Thank you very much. I would like to welcome you to the Ãssur investor conference call where we will cover the results for the 2nd quarter of 2019. My name is Jón Sigurdsson, and I'm the President and CEO. And with me here today is Sveinn Sölvason, our CFO. We will begin by going through the highlights of the quarter and with our guidance for 2019. A question-and-answer session will then follow.

Sales in the first quarter of the year amounted to $179 million corresponding to 18% growth in local currency, 7% organic growth in 13% reported growth in US dollars. In the first half of the year, local currency growth amounted to 19% and organic growth was 7%. EBITDA grew by 33% in the quarter and amounted to $42 million or 24% of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot